Eli Lilly’s Weight Loss Drug Tirzepatide: A Breakthrough in Reducing Type 2 Diabetes Risk

Eli Lilly’s Weight Loss Drug Tirzepatide: A Breakthrough in Reducing Type 2 Diabetes Risk Eli Lilly and Company has recently made headlines with its groundbreaking weight loss drug, tirzepatide, which has demonstrated an impressive 94% reduction in the risk of developing type 2 diabetes among overweight or obese adults with prediabetes. This remarkable finding emerged […]